SIREN : 848058046
HOLDING PHARMACIE EIFFEL is a French company founded 7 years ago, specialized in the sector Activités des sièges sociaux. Based in DIJON (21000), this company of category PME shows in 2025 a net income positive of 97 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
| Net income | 97 181 € | 125 605 € | 124 354 € | 126 030 € | 135 442 € | 65 160 € | -29 092 € |
| EBITDA | -4 173 € | -3 825 € | -3 718 € | -3 539 € | -3 475 € | -4 555 € | -28 912 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
In 2025, HOLDING PHARMACIE EIFFEL generates positive net income of 97 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
-4 173 €
-4 173 €
97 181 €
The debt ratio (= Financial debt / Equity x 100) stands at 74%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 6.2 years of cash flow to repay all financial debt. This ratio remains within usual banking standards.
73.845%
57.248%
6.168
In 2025, the debt ratio of HOLDING PHARMACIE EIFFEL (73.84) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of HOLDING PHARMACIE EIFFEL (57.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2025, the repayment capacity of HOLDING PHARMACIE EIFFEL (6.17) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 2136.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
2136.423
-110.52
In 2025, the liquidity ratio of HOLDING PHARMACIE EIFFEL (2136.42) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2025, the interest coverage of HOLDING PHARMACIE EIFFEL (-110.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 54 transactions of similar company sales
in 2025,
the value of HOLDING PHARMACIE EIFFEL is estimated at
268 669 €
(range 80 962€ - 553 143€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare HOLDING PHARMACIE EIFFEL with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of HOLDING PHARMACIE EIFFEL is not publicly disclosed (confidential accounts filed with INPI).
Yes, HOLDING PHARMACIE EIFFEL generated a net profit of 97 k€ in 2025.
The headquarters of HOLDING PHARMACIE EIFFEL is located in DIJON (21000), in the department Cote-d'Or.
The tax return of HOLDING PHARMACIE EIFFEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
HOLDING PHARMACIE EIFFEL operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.